#VisualAbstract: Oral Glucose-Lowering Agents are Not Noninferior to Insulin for Gestational Diabetes
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: metformin
Early intensive glycemic control reduces long-term risk of death and myocardial infarction in patients with type 2 diabetes
1. Sulfonylurea, insulin therapy, and metformin resulted in a significant relative risk reduction for all-cause mortality and myocardial infarction. 2. ...
Metformin may reduce all-cause mortality in cancer survivors
1. Among US cancer survivors, metformin was associated with a lower risk of cardiometabolic diseases, all-cause mortality, and cardiometabolic mortality. ...
Metformin use may decrease risk of osteoarthritis development
1. In this retrospective cohort study, individuals with diabetes treated with metformin had a significantly lower risk of developing osteoarthritis ...
Meta-analysis shows significant decrease in age-related macular degeneration risk with metformin use
1. In a systematic review and meta-analysis of observational studies on patients with diabetes, metformin use was associated with a ...
Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists improve diabetes outcomes but are not cost effective
1. For sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP1) receptor agonists to be used as first-line agents for type ...
Glargine and liraglutide are effective glucose-lowering medications in type 2 diabetes
1. Compared to sitagliptin and glimepiride, glargine and liraglutide were more effective in achieving target glycated hemoglobin levels in patients ...
![Type I diabetes not associated with early menopause [OVADIA study]](https://www.2minutemedicine.com/wp-content/uploads/2014/12/diabetes1_edited-350x250.jpg)
Adjunctive glucose-lower therapies do not decrease risk of microvascular complications in diabetic patients
1. No significant differences in vascular complications of diabetes were seen in patients using metformin and adjunctive glargine, liraglutide, glimepiride, ...
Metformin, ivermectin, and fluvoxamine do not prevent severe SARS-CoV-2 infection
1. Metformin, ivermectin, and fluvoxamine do not prevent hypoxemia, emergency department visits, hospitalization, or death in coronavirus disease 2019 (COVID-19) ...
#VisualAbstract: Metformin does not improve survival in patients with high-risk, nonmetastatic breast cancer
Click to read this study in JAMA.